S&P 500   3,171.64 (+0.96%)
DOW   28,188.39 (+0.99%)
QQQ   207.06 (+1.01%)
FB   203.16 (+0.44%)
MSFT   153.00 (+0.86%)
GOOGL   1,351.55 (+0.54%)
AMZN   1,757.26 (+0.49%)
CGC   20.48 (+1.14%)
MU   50.98 (+3.49%)
BABA   205.32 (+0.33%)
GE   11.47 (+4.46%)
TSLA   361.87 (+2.60%)
T   38.49 (+0.81%)
AMD   41.18 (+4.33%)
ACB   2.46 (+0.41%)
F   9.27 (+1.76%)
PRI   137.15 (+1.26%)
BAC   34.25 (+1.81%)
GILD   67.71 (-0.10%)
DIS   148.18 (+0.40%)
S&P 500   3,171.64 (+0.96%)
DOW   28,188.39 (+0.99%)
QQQ   207.06 (+1.01%)
FB   203.16 (+0.44%)
MSFT   153.00 (+0.86%)
GOOGL   1,351.55 (+0.54%)
AMZN   1,757.26 (+0.49%)
CGC   20.48 (+1.14%)
MU   50.98 (+3.49%)
BABA   205.32 (+0.33%)
GE   11.47 (+4.46%)
TSLA   361.87 (+2.60%)
T   38.49 (+0.81%)
AMD   41.18 (+4.33%)
ACB   2.46 (+0.41%)
F   9.27 (+1.76%)
PRI   137.15 (+1.26%)
BAC   34.25 (+1.81%)
GILD   67.71 (-0.10%)
DIS   148.18 (+0.40%)
S&P 500   3,171.64 (+0.96%)
DOW   28,188.39 (+0.99%)
QQQ   207.06 (+1.01%)
FB   203.16 (+0.44%)
MSFT   153.00 (+0.86%)
GOOGL   1,351.55 (+0.54%)
AMZN   1,757.26 (+0.49%)
CGC   20.48 (+1.14%)
MU   50.98 (+3.49%)
BABA   205.32 (+0.33%)
GE   11.47 (+4.46%)
TSLA   361.87 (+2.60%)
T   38.49 (+0.81%)
AMD   41.18 (+4.33%)
ACB   2.46 (+0.41%)
F   9.27 (+1.76%)
PRI   137.15 (+1.26%)
BAC   34.25 (+1.81%)
GILD   67.71 (-0.10%)
DIS   148.18 (+0.40%)
S&P 500   3,171.64 (+0.96%)
DOW   28,188.39 (+0.99%)
QQQ   207.06 (+1.01%)
FB   203.16 (+0.44%)
MSFT   153.00 (+0.86%)
GOOGL   1,351.55 (+0.54%)
AMZN   1,757.26 (+0.49%)
CGC   20.48 (+1.14%)
MU   50.98 (+3.49%)
BABA   205.32 (+0.33%)
GE   11.47 (+4.46%)
TSLA   361.87 (+2.60%)
T   38.49 (+0.81%)
AMD   41.18 (+4.33%)
ACB   2.46 (+0.41%)
F   9.27 (+1.76%)
PRI   137.15 (+1.26%)
BAC   34.25 (+1.81%)
GILD   67.71 (-0.10%)
DIS   148.18 (+0.40%)
Log in

NASDAQ:BABY - Natus Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$31.17
-0.29 (-0.92 %)
(As of 12/12/2019 10:00 AM ET)
Today's Range
$30.98
Now: $31.17
$31.83
50-Day Range
$26.75
MA: $29.96
$31.92
52-Week Range
$23.53
Now: $31.17
$37.90
Volume127,207 shs
Average Volume165,325 shs
Market Capitalization$1.06 billion
P/E Ratio21.95
Dividend YieldN/A
Beta0.57
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530.89 million
Cash Flow$3.32 per share
Book Value$11.80 per share

Profitability

Net Income$-22,930,000.00

Miscellaneous

Employees1,729
Market Cap$1.06 billion
Next Earnings Date2/11/2020 (Estimated)
OptionableOptionable

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.


Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical declared that its Board of Directors has initiated a share buyback plan on Thursday, February 22nd 2018, which authorizes the company to repurchase $30,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its stock is undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) posted its quarterly earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.42 by $0.02. The medical equipment provider earned $130.60 million during the quarter, compared to analysts' expectations of $132.92 million. Natus Medical had a positive return on equity of 10.79% and a negative net margin of 7.38%. The firm's revenue was up 6.5% on a year-over-year basis. During the same quarter last year, the business posted $0.40 earnings per share. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Natus Medical.

What is the consensus analysts' recommendation for Natus Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Natus Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Natus Medical.

Has Natus Medical been receiving favorable news coverage?

News stories about BABY stock have trended negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Natus Medical earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Natus Medical.

Who are some of Natus Medical's key competitors?

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Activision Blizzard (ATVI), Walt Disney (DIS), Gilead Sciences (GILD), Intel (INTC), Skyworks Solutions (SWKS), Celgene (CELG), Alphabet (GOOG), NVIDIA (NVDA) and Tesla (TSLA).

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)
  • Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)
  • Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)
  • Mr. Seán Langan, VP Global Operations
  • Mr. Ivan Pandiyan, VP of Global R&D

Who are Natus Medical's major shareholders?

Natus Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (3.48%), Millennium Management LLC (0.39%), California State Teachers Retirement System (0.15%), Squarepoint Ops LLC (0.12%), Barclays PLC (0.11%) and Metropolitan Life Insurance Co NY (0.03%). Company insiders that own Natus Medical stock include Austin Francis Noll III, Dong Chune Christopher Chung, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Lisa Wipperman Heine, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Which institutional investors are selling Natus Medical stock?

BABY stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Squarepoint Ops LLC and Barclays PLC. Company insiders that have sold Natus Medical company stock in the last year include Austin Francis Noll III, Dong Chune Christopher Chung, Ken Ludlum and Robert A Gunst. View Insider Buying and Selling for Natus Medical.

Which institutional investors are buying Natus Medical stock?

BABY stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, California State Teachers Retirement System and Metropolitan Life Insurance Co NY. View Insider Buying and Selling for Natus Medical.

What is Natus Medical's stock price today?

One share of BABY stock can currently be purchased for approximately $31.17.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.06 billion and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical.

What is Natus Medical's official website?

The official website for Natus Medical is http://www.natus.com/.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (NASDAQ BABY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  284 (Vote Outperform)
Underperform Votes:  308 (Vote Underperform)
Total Votes:  592
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel